BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

MLYS upcoming catalysts

Mineralys Therapeutics Inc.: 0 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (0 Phase 3), 1 upcoming FDA decision event(s), and in the last 12 months 2 readout(s) and 1 FDA event(s). Subscribe to MLYS (.ics).

Drugs: lorundrostat

Upcoming FDA decision events

DateEventStatusCompanyDrugSource
2026-12-22PDUFA date (company-disclosed)pendingMineralys Therapeutics, Inc. MLYSlorundrostatPDUFA December 22, 2026 - Mineralys Therapeutics, Inc. (lorundrostat)

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
No trials in this window.

FDA decision events, last 12 months

DateEventStatusCompanyDrugSource
2026-04-01 (quarter)PDUFA date (company-disclosed)date passedMineralys Therapeutics, Inc. MLYSPDUFA second quarter of 2026 - Mineralys Therapeutics, Inc.

Trial readouts, last 12 months

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2025-12-30P3Mineralys Therapeutics Inc. MLYSNCT05968430 Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionHypertensionactive not recruiting1076
2025-12-17P2Mineralys Therapeutics Inc. MLYSNCT06785454 A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and HypertensionObstructive Sleep Apnea; Hypertensioncompleted48

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.